282 related articles for article (PubMed ID: 23284167)
1. Small molecule targeting Cdc42-intersectin interaction disrupts Golgi organization and suppresses cell motility.
Friesland A; Zhao Y; Chen YH; Wang L; Zhou H; Lu Q
Proc Natl Acad Sci U S A; 2013 Jan; 110(4):1261-6. PubMed ID: 23284167
[TBL] [Abstract][Full Text] [Related]
2. A Cdc42 mutant specifically activated by intersectin.
Smith WJ; Hamel B; Yohe ME; Sondek J; Cerione RA; Snyder JT
Biochemistry; 2005 Oct; 44(40):13282-90. PubMed ID: 16201754
[TBL] [Abstract][Full Text] [Related]
3. Enabling Systemic Identification and Functionality Profiling for Cdc42 Homeostatic Modulators.
Malasala S; Azimian F; Chen YH; Twiss JL; Boykin C; Akhtar SN; Lu Q
bioRxiv; 2024 Jan; ():. PubMed ID: 38260445
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Cdc42-intersectin interaction by small molecule ZCL367 impedes cancer cell cycle progression, proliferation, migration, and tumor growth.
Aguilar BJ; Zhao Y; Zhou H; Huo S; Chen YH; Lu Q
Cancer Biol Ther; 2019; 20(6):740-749. PubMed ID: 30849276
[TBL] [Abstract][Full Text] [Related]
5. Targeting Cdc42 with the small molecule drug AZA197 suppresses primary colon cancer growth and prolongs survival in a preclinical mouse xenograft model by downregulation of PAK1 activity.
Zins K; Gunawardhana S; Lucas T; Abraham D; Aharinejad S
J Transl Med; 2013 Nov; 11():295. PubMed ID: 24279335
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a Cdc42 protein inhibitor and its use as a molecular probe.
Hong L; Kenney SR; Phillips GK; Simpson D; Schroeder CE; Nöth J; Romero E; Swanson S; Waller A; Strouse JJ; Carter M; Chigaev A; Ursu O; Oprea T; Hjelle B; Golden JE; Aubé J; Hudson LG; Buranda T; Sklar LA; Wandinger-Ness A
J Biol Chem; 2013 Mar; 288(12):8531-8543. PubMed ID: 23382385
[TBL] [Abstract][Full Text] [Related]
7. Novel Activities of Select NSAID R-Enantiomers against Rac1 and Cdc42 GTPases.
Oprea TI; Sklar LA; Agola JO; Guo Y; Silberberg M; Roxby J; Vestling A; Romero E; Surviladze Z; Murray-Krezan C; Waller A; Ursu O; Hudson LG; Wandinger-Ness A
PLoS One; 2015; 10(11):e0142182. PubMed ID: 26558612
[TBL] [Abstract][Full Text] [Related]
8. A Rac/Cdc42-specific exchange factor, GEFT, induces cell proliferation, transformation, and migration.
Guo X; Stafford LJ; Bryan B; Xia C; Ma W; Wu X; Liu D; Songyang Z; Liu M
J Biol Chem; 2003 Apr; 278(15):13207-15. PubMed ID: 12547822
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of guanine nucleotide exchange and Rac-mediated signaling revealed by a dominant negative trio mutant.
Debreceni B; Gao Y; Guo F; Zhu K; Jia B; Zheng Y
J Biol Chem; 2004 Jan; 279(5):3777-86. PubMed ID: 14597635
[TBL] [Abstract][Full Text] [Related]
10. Intersectin-2L regulates caveola endocytosis secondary to Cdc42-mediated actin polymerization.
Klein IK; Predescu DN; Sharma T; Knezevic I; Malik AB; Predescu S
J Biol Chem; 2009 Sep; 284(38):25953-61. PubMed ID: 19622753
[TBL] [Abstract][Full Text] [Related]
11. DEF6, a novel PH-DH-like domain protein, is an upstream activator of the Rho GTPases Rac1, Cdc42, and RhoA.
Mavrakis KJ; McKinlay KJ; Jones P; Sablitzky F
Exp Cell Res; 2004 Apr; 294(2):335-44. PubMed ID: 15023524
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic Dbl, Cdc42, and p21-activated kinase form a ternary signaling intermediate through the minimum interactive domains.
Wang L; Zhu K; Zheng Y
Biochemistry; 2004 Nov; 43(46):14584-93. PubMed ID: 15544329
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a Dual Rac/Cdc42 Inhibitor MBQ-167 in Metastatic Cancer.
Humphries-Bickley T; Castillo-Pichardo L; Hernandez-O'Farrill E; Borrero-Garcia LD; Forestier-Roman I; Gerena Y; Blanco M; Rivera-Robles MJ; Rodriguez-Medina JR; Cubano LA; Vlaar CP; Dharmawardhane S
Mol Cancer Ther; 2017 May; 16(5):805-818. PubMed ID: 28450422
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of human Intersectin-2L C2 domain.
Zhang W; Shen Y; Xiong G; Guo Y; Deng L; Li B; Yang J; Qi C
Biochem Biophys Res Commun; 2013 Feb; 431(1):76-80. PubMed ID: 23274495
[TBL] [Abstract][Full Text] [Related]
15. Molecular basis for Rac1 recognition by guanine nucleotide exchange factors.
Karnoub AE; Worthylake DK; Rossman KL; Pruitt WM; Campbell SL; Sondek J; Der CJ
Nat Struct Biol; 2001 Dec; 8(12):1037-41. PubMed ID: 11685227
[TBL] [Abstract][Full Text] [Related]
16. Unraveling the molecular mechanism of interactions of the Rho GTPases Cdc42 and Rac1 with the scaffolding protein IQGAP2.
Ozdemir ES; Jang H; Gursoy A; Keskin O; Li Z; Sacks DB; Nussinov R
J Biol Chem; 2018 Mar; 293(10):3685-3699. PubMed ID: 29358323
[TBL] [Abstract][Full Text] [Related]
17. Intersectin-Cdc42 interaction is required for orderly meiosis in porcine oocytes.
Li X; Gao M; He Y; Xiong B; Liu H; Gu L
J Cell Physiol; 2019 May; 234(5):7492-7497. PubMed ID: 30478952
[TBL] [Abstract][Full Text] [Related]
18. The guanine nucleotide exchange factor Tiam1: a Janus-faced molecule in cellular signaling.
Boissier P; Huynh-Do U
Cell Signal; 2014 Mar; 26(3):483-91. PubMed ID: 24308970
[TBL] [Abstract][Full Text] [Related]
19. Selective activation by the guanine nucleotide exchange factor Don1 is a main determinant of Cdc42 signalling specificity in Ustilago maydis.
Hlubek A; Schink KO; Mahlert M; Sandrock B; Bölker M
Mol Microbiol; 2008 May; 68(3):615-23. PubMed ID: 18394145
[TBL] [Abstract][Full Text] [Related]
20. Novel Coronin7 interactions with Cdc42 and N-WASP regulate actin organization and Golgi morphology.
Bhattacharya K; Swaminathan K; Peche VS; Clemen CS; Knyphausen P; Lammers M; Noegel AA; Rastetter RH
Sci Rep; 2016 May; 6():25411. PubMed ID: 27143109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
